Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT India 100BT GolfBT Mindrush
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Rekvina Labs Ltd
Rekvina Labs Ltd

Rekvina Labs Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 21
Dec 13, 2021
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹4.50
₹0.00 (0.00%)
4.50Low
Today’s Performance
4.50High
-Low
52 Week’s Performance
4.50High

bt_logoStock Performance

  • 1 Day-%
  • 1 Week-%
  • 1 Month-%
  • 3 Months12.78%
  • 6 Months25.00%
  • 1 Year7.91%
  • 3 Years-3.77%
  • 5 Years-8.27%

bt_logoStock Summary

  • Face Value (₹)5.00
  • Beta-
  • 52-Week Low (₹)-
  • 52-Week High (₹)-
  • Price-to-Book (X)*875.03
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*-
  • Earnings Per Share (₹)-0.02
  • Market Cap (₹ Cr.)*2.71
* Values as of last close price

bt_logoCOMPETITORS

BT TV

FM Sitharaman Hopes For Debate On Simplified New Income Tax Bill In Parliament2:57FM Sitharaman Hopes For Debate On Simplified New Income Tax Bill In Parliament
Top Industry Leaders On The Road Ahead For The India-US Trade Deal5:02Top Industry Leaders On The Road Ahead For The India-US Trade Deal
From Millet Buns To Protein Slices- Mc Donalds Reinvents Everyday Eating5:26From Millet Buns To Protein Slices- Mc Donalds Reinvents Everyday Eating
Dr Reddy's Q1 Results: Revenue Zooms 11% | Top Management Decodes Growth Plans11:57New Markets, Therapies Drive Dr. Reddy’s
Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today49:11Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today
India-UK FTA: Piyush Goyal Highlights Social Security Win For Indian Professionals3:47India-UK FTA: Piyush Goyal Highlights Social Security Win For Indian Professionals
India’s Bilateral Trade Game Plan | Sunil Bharti Mittal Exclusive4:32India’s Bilateral Trade Game Plan | Sunil Bharti Mittal Exclusive
Explained | India–UK FTA Signed | What Does This Landmark Deal Mean For Trade & Industry?17:29Explained | India–UK FTA Signed | What Does This Landmark Deal Mean For Trade & Industry?
Mayuresh Joshi Highlights Stocks & Sectors That Will Benefit From The India-UK Free Trade Agreement2:29Mayuresh Joshi Highlights Stocks & Sectors That Will Benefit From The India-UK Free Trade Agreement
Trump Slams Fed’s ‘Wasteful’ Renovation As Powell Pushes Back In Helmet Showdown4:22Trump Slams Fed’s ‘Wasteful’ Renovation As Powell Pushes Back In Helmet Showdown
View more

bt_logoFAQ's

What was Rekvina Labs Ltd share price previously?
Rekvina Labs Ltd share price was down by 0.00% from the previous closing price of ₹4.50.
Who are peers of Rekvina Labs Ltd?
The peers of Rekvina Labs Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Rekvina Labs Ltd?
The promotor/promotors of Rekvina Labs Ltd are Amit Mukeshbhai Shah, Bhavesh Vora, Nilesh Harkesh Yadav, Jaishree Babulal Jain, Dhruval Patel, Surbhit Shah, Chetanbhai Patel, Ilaben Pathak.
What has been 52-week high of Rekvina Labs Ltd stocks?
The highest price of Rekvina Labs Ltd stock is ₹0.00 in the last 52-week.
What is the share price of Rekvina Labs Ltd (VINRKLB) today on BSE?
As on Dec 13, 2021 Rekvina Labs Ltd (VINRKLB)’s share price on BSE is Rs 4.5
What is the market cap of Rekvina Labs Ltd (VINRKLB)?
The current market capitalisation of Rekvina Labs Ltd (VINRKLB) is 2.71 crores
What is Rekvina Labs Ltd Share symbol?
The symbol of Rekvina Labs Ltd is .
What is the PE ratio of Rekvina Labs Ltd (VINRKLB)?
The current PE ratio of Rekvina Labs Ltd (VINRKLB) is -.
What is the PB ratio of Rekvina Labs Ltd (VINRKLB)?
The current PB ratio of Rekvina Labs Ltd (VINRKLB) is 875.03.
Today’s High & Low share prices of Rekvina Labs Ltd (VINRKLB) on BSE?
Today, the share price of Rekvina Labs Ltd (VINRKLB) on BSE touched a high of Rs 4.5 and a low of Rs 4.5
What price did Rekvina Labs Ltd (VINRKLB) shares open on the BSE today?
On BSE, the share price of Rekvina Labs Ltd (VINRKLB) opened at Rs 4.5
What is the 52-week high of Rekvina Labs Ltd (VINRKLB)?
The 52-week high price of Rekvina Labs Ltd (VINRKLB) is Rs 4.50
What is the 52-week low of Rekvina Labs Ltd (VINRKLB)?
The 52-week low price of Rekvina Labs Ltd (VINRKLB) is Rs -

bt_logoAbout Rekvina Labs

Rekvina Labs Ltd, incorporated in the year 1988, has its registered office in 328 Paradise Complex, Sayajigunj, Vadodara, Gujarat, 390005, 91-265-2362966. The main industry in which Rekvina Labs Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Rekvina Labs Ltd is/are Jigar Adhyaru & Co/TDK & Co. In the main management, is chairman and is the company secretary for Rekvina Labs Ltd.

  • AMS
    Amit Mukeshbhai ShahManaging Director
  • BV
    Bhavesh VoraIndependent Director
  • NHY
    Nilesh Harkesh YadavIndependent Director
  • JBJ
    Jaishree Babulal JainExecutive Director
  • DP
    Dhruval PatelIndependent Director
  • SS
    Surbhit ShahExecutive Director
  • CP
    Chetanbhai PatelIndependent Director
  • IP
    Ilaben PathakIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.